The Advent of Generative Chemistry.

Area of Science:

• Artificial Intelligence
• Deep Learning
• Reinforcement Learning
• Pharmacology
• Generative Chemistry

Background:

• Generative adversarial networks (GANs), introduced in 2014, are a key AI concept.
• GANs combine deep learning and game theory to create novel data instances.
• Since 2016, GANs coupled with reinforcement learning (RL) have been applied to de novo molecular design in pharmacology.

Purpose of the Study:

• To review recent advancements in generating novel molecules with desired properties.
• To focus on the applications of GANs, RL, and related techniques in generative chemistry.
• To discuss current limitations and challenges in the field of generative chemistry.

Main Methods:

• Review of recent literature on generative models in molecular design.
• Focus on the integration of Generative Adversarial Networks (GANs) and Reinforcement Learning (RL).
• Analysis of techniques for exploring chemical space and efficient data utilization.

Main Results:

• GANs and RL have shown success in de novo molecular design for pharmacology.
• These methods aim for more efficient data usage and better exploration of chemical space.
• Recent advances focus on generating molecules with specific, desired properties.

Conclusions:

• Generative chemistry, utilizing GANs and RL, is a rapidly growing field.
• These AI-driven approaches offer significant potential for drug discovery and development.
• Addressing current limitations is crucial for future progress in generative chemistry.